Advanced Biomed Common Stock Today
| ADVB Stock | 0.28 0 1.36% |
PerformanceWeakest
| Odds Of DistressRisky
|
Advanced Biomed is trading at 0.2838 as of the 3rd of February 2026, a 1.36 percent up since the beginning of the trading day. The stock's open price was 0.28. Advanced Biomed has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 5th of November 2025 and ending today, the 3rd of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 6th of March 2025 | Category Healthcare | Classification Health Care |
Advanced Biomed is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 21.64 M outstanding shares of which 241.68 K shares are presently shorted by private and institutional investors with about 3.31 trading days to cover. More on Advanced Biomed Common
Moving together with Advanced Stock
| 0.73 | BSX | Boston Scientific Corp Earnings Call Tomorrow | PairCorr |
Moving against Advanced Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Advanced Stock Highlights
| CEO Chairman | Yi Lu | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAdvanced Biomed can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Advanced Biomed's financial leverage. It provides some insight into what part of Advanced Biomed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Advanced Biomed Common (ADVB) is traded on NASDAQ Exchange in USA and employs 31 people. Advanced Biomed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.53 M. Advanced Biomed Common conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 21.64 M outstanding shares of which 241.68 K shares are presently shorted by private and institutional investors with about 3.31 trading days to cover.
Advanced Biomed generates negative cash flow from operations
Check Advanced Biomed Probability Of Bankruptcy
Ownership AllocationAdvanced Biomed holds a total of 21.64 Million outstanding shares. Advanced Biomed Common shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 83.12 percent of Advanced Biomed Common outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Advanced Ownership Details
Advanced Biomed Historical Income Statement
Advanced Stock Against Markets
Already Invested in Advanced Biomed Common?
The danger of trading Advanced Biomed Common is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Advanced Biomed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Advanced Biomed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Advanced Biomed Common is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Biomed Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Advanced Biomed assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Advanced Biomed Common requires distinguishing between market price and book value, where the latter reflects Advanced's accounting equity. The concept of intrinsic value—what Advanced Biomed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Advanced Biomed's price substantially above or below its fundamental value.
Understanding that Advanced Biomed's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Advanced Biomed represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Advanced Biomed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.